Anti-HLA E antibody [MEM-E/02],Abcam,AB2216

What is this antibody validated in? Anti-HLA E antibody [MEM-E/02] (ab2216) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples. What is the molecular weight of HLA E? Anti-HLA E [MEM-E/02] (ab2216) specifically detects a band for HLA E (UniProt: P13747) at a molecular weight of 40kDa. Trusted by the scientific community Anti-HLA E [MEM-E/02] (ab2216) was first used in a scientific publication in 2002 and has been cited over 20 times in peer-reviewed journals. Reviewed by scientists Anti-HLA E [MEM-E/02] (ab2216) has over 5 independent reviews from customers. Specificity confirmed The specificity of Anti-HLA E antibody [MEM-E/02] (ab2216) has been confirmed by Western blot testing in HLA-E Knockout A549 cell line, ab267231 .

Host

Mouse

Reactivity

Human

Application

IHC-P, WB, Flow Cyt

Platform ID

BAB272402271

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-HLA E antibody [MEM-E/02]
Cat. No.AB2216
HostMouse
IsotypeIgG1
ReactivityHuman
ApplicationIHC-P, WB, Flow Cyt
ClonalityMonoclonal
Clone NumberMEM-E/02
Concentration1 mg/mL Batch dependent concentration
ImmunogenRecombinant Full Length Protein corresponding to Human HLA-E.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Non-classical major histocompatibility class Ib molecule involved in immune self-nonself discrimination. In complex with B2M/beta-2-microglobulin binds nonamer self-peptides derived from the signal sequence of classical MHC class Ia molecules (VL9 peptides - VMAPRT[V/L][L/V/I/F]L) (PubMed : 18083576, PubMed : 18339401, PubMed : 35705051, PubMed : 37264229, PubMed : 9754572). Peptide-bound HLA-E-B2M heterotrimeric complex primarily functions as a ligand for natural killer (NK) cell inhibitory receptor KLRD1-KLRC1, enabling NK cells to monitor the expression of other MHC class I molecules in healthy cells and to tolerate self (PubMed : 17179229, PubMed : 18083576, PubMed : 37264229, PubMed : 9486650, PubMed : 9754572). Upon cellular stress, preferentially binds signal sequence-derived peptides from stress-induced chaperones and is no longer recognized by NK cell inhibitory receptor KLRD1-KLRC1, resulting in impaired protection from NK cells (PubMed : 12461076). Binds signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules and acts as a ligand for NK cell activating receptor KLRD1-KLRC2, likely playing a role in the generation and effector functions of adaptive NK cells and in maternal-fetal tolerance during pregnancy (PubMed : 30134159, PubMed : 37264229, PubMed : 9754572). Besides self-peptides, can also bind and present pathogen-derived peptides conformationally similar to VL9 peptides to alpha-beta T cell receptor (TCR) on unconventional CD8-positive cytotoxic T cells, ultimately triggering antimicrobial immune response (PubMed : 16474394, PubMed : 20195504, PubMed : 30087334, PubMed : 34228645). Presents HIV gag peptides (immunodominant KAFSPEVIPMF and subdominant KALGPAATL epitopes) predominantly to CD8-positive T cell clones expressing a TRAV17-containing TCR, triggering HLA-E-restricted T cell responses (PubMed : 34228645). Presents mycobacterial peptides to HLA-E-restricted CD8-positive T cells eliciting both cytotoxic and immunoregulatory functions (PubMed : 20195504, PubMed : 35705051).. (Microbial infection) Viruses like human cytomegalovirus have evolved an escape mechanism whereby virus-induced down-regulation of host MHC class I molecules is coupled to the binding of viral peptides to HLA-E, restoring HLA-E expression and inducing HLA-E-dependent NK cell immune tolerance to infected cells.. (Microbial infection) May bind HIV-1 gag/Capsid protein p24-derived peptide (AISPRTLNA) on infected cells and may inhibit NK cell cytotoxicity, a mechanism that allows HIV-1 to escape immune recognition.. (Microbial infection) Upon SARS-CoV-2 infection, may contribute to functional exhaustion of cytotoxic NK cells and CD8-positive T cells (PubMed : 32859121). Binds SARS-CoV-2 S/Spike protein S1-derived peptide (LQPRTFLL) expressed on the surface of lung epithelial cells, inducing NK cell exhaustion and dampening of antiviral immune surveillance (PubMed : 32859121). See full target information HLA-E

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.